Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Inovio Pharmaceuticals, Inc. (NASDAQ: INO).

Full DD Report for INO

You must become a subscriber to view this report.

Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on INO.

About Inovio Pharmaceuticals, Inc. (NASDAQ: INO)

Logo for Inovio Pharmaceuticals, Inc. (NASDAQ: INO)

The achievements of stimulating the immune system through vaccination have been profound. INO s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO s SynCon vaccines are designed to provide universal cross strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio s proprietary electroporation delivery, have been shown in humans to generate best in class immune responses with a favorable safety profile.


Contact Information



Current Management

  • Terry E. Gibson / COO
  • Peter Kies / CFO
  • E. Terrie RoeDierlam / Secretary

Current Share Structure

  • Market Cap: $455,635,419 - 05/17/2018
  • Issue and Outstanding: 90,403,853 - 03/08/2018


Daily Technical Chart for (NASDAQ: INO)

Daily Technical Chart for (NASDAQ: INO)

Stay tuned for daily updates and more on (NASDAQ: INO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: INO)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in INO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of INO and does not buy, sell, or trade any shares of INO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: